|
|
1. James A. Jorgenson, RPh, MS, FASHP; Susan Spivey, RPh, DDS, PharmD; Cam Au, PharmD; David Canann, PharmD; Howard Ritter, PharmD; Bart Smith, Senior Pharmacy Intern.
Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs.
Hospital Pharmacy, Volume 43, Number 9, pp 723-727, September 2008.
2. James A. Jorgenson, RPh, MS, FASHP. Leakproof Connection Integrity Test for Devices Intended for Handling Hazardous Drugs. Presented at the ASHP Midyear Clinical Meeting, December 2007.
3. James A. Jorgenson, RPh, MS, FASHP. 2007 Utah Protocol Update: Evaluation of Vial Transfer Devices for Containment of Hazardous Drug Vapors. Presented at ASHP Midyear Clinical Meeting, December 2007.
4. Spivey Susan, RPh, DDS, PharmD and Jorgenson A. James, RPh, MS, FASHP.
Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs.
Presented at the Oncology Nursing Society, 32nd Annual Congress, April 24–27, 2007, Las Vegas, NV
5. Nyman A. Heather, PharmD, Jorgenson A. James, MS, FASHP, and Slawson H. Matthew, PhD.Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device.
Hospital Pharmacy, Volume 42, Number 3, pp 219–225, 2007.
6. Au C, Jorgenson J, Smith B. Evaluation of Vial Transfer Devices for Containment of Hazardous Drug Vapors. Presented at UHC Resident Poster Session, ASHP Mid Year Clinical Meeting, December 3-7, 2006 · Anaheim CA.
Download publication
View video (QuickTime)
7. Landini M. Kimberly, Pharm. D. Implementation of a safety device for use in preparing and administering cytotoxic medications in an inpatient setting (P360D).
ASHP Abstracts & Program Resources on CDROM 2006 Midyear Clinical Meeting December 3-7, 2006 · Anaheim CA
Download publication
8. Miyamatsu H, Sakamoto M, Azuma K, Ishii F, Mae A, Satou K, Koura C, Kouno K, Saito K, Abe M, Akashi T Evaluation of Operability of the PhaSeal system, a Sealed Handling Device for Anticancer Agents Japanese Journal of Pharmaceutical Health Care and Sciences Vol.32, No.12, December 2006
9. Harrison B, Peters B, Bing M Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. American Journal of Health-System Pharmacy, Vol. 63, Issue 18, 2006, 1736-1744
Abstract
10. ASHP Guidelines on handling hazardous drugs. Developed by the ASHP Council on professional affairs and approved by the ASHP board of directors on January 12 2006. Am J Health-Syst Pharm. 2006;63:1172-93.
Download publication
11. Poirier S, Jones C, Calvert MJ Practical implementation of a closed system (PhaSeal) for the preparation, administration and disposal of Cytotoxic drugs in a busy ambulatory cancer centre. J Oncol Pharm Practice, Vol 10:No 2, 2004 p81
Abstract
12. Tans Birgit, Willems Ludo.
Comparative contamination study with cyclophosphamide, fluorouracil and ifosfamide: standard versus a proprietary closed-handling system.
J Oncol Pharm Practice, Vol 10: No 4, 2004 p217-223
13. Spivey S, Connor TH Determining sources of
workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hosp Pharm 2003, 38(2):135-139
Abstract
14. Wick C, Slawson MH, Jorgenson JA et al. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm 60:2314-2320
Abstract
15. Connor TH, Anderson RW, Sessink PJM et al. Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area. Am J Health-Syst Pharm - Vol 59, Jan 1, 2002;59:68-72
Abstract
16. Nygren O, Gustavsson B, Ström I et al . Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and closed system. J. Environ. Monit, 2002,4, 739-742
Abstract
17. Vandenbroucke J. How to protect environment and employees against cytotoxic agents, the UZ Ghent experience. J Oncol Pharm Pratice, Vol 6, No 4, 2001: pp 146-152.
Abstract
18. Ferencak H. Alissa, Kopp A. Monica, Hausermann M. Donna.
Implementation of Safer Chemotherapy Systems Utilized in a VA Medical Center.
Presented at ASHP Midyear Meeting, 2000
19. Sessink PJM, Rolf ME, Ryden NS. Evaluation of the PhaSeal Hazardous Drug Containment System. Hospital Pharmacy Vol 34 No. 11 Nov 1999, 1311-1317
Abstract
20. Nygren O, Kragh E, Lundgren C, et al.
Presentation 1: Determination of spill and airborne emission during preparation of drugs using different preparation techniques;
Presentation 2: Emission and leakage during preparation of cytotoxic drugs. International symposium on modern principles of workplace air moni to ring, 3:rd, Geilo, Norway, 1999.
21. Gustavsson B. Evaluation of technetium assay for monitoring of occupational exposure to cytotoxic drugs. J Oncol Pharm Practice 1997; 3: 46
Abstract
|
